Peer-Reviewed Publications

- Publication h-index=32 (The h-index considers Scopus articles published from 1995 forward)

The h-index is based upon the number of documents and number of citations so it measures both the productivity and citation impact of the publications. For example, an h-index of 32 means the author has at least 32 publications that were cited at least 32 times.

Peer-Reviewed Papers

    1. Christine A. Radawski, Tarek A. Hammad, Susan Colilla, Paul Coplan, Kenneth Hornbuckle, Emily Freeman, Meredith Y. Smith, Rachel E. Sobel, Priya Bahri, Ariel E. Arias, Dimitri Bennett. “The Utility of Real-World Evidence for Benefit Risk Assessment, Communication, and Evaluation of Pharmaceuticals: Case studies”. Pharmacoepidemiology and Drug Safety 2020;1–8.

    2. Cathy Anne Pinto, Tommi Tervonen, Kevin Marsh, Dimitra Lambrelli, Anna Schultze, Andrew Tershakovec, Johanna Hyacinthe, Thibaud Prawitz, Tarek A. Hammad. "Personalized Benefit Risk Assessments Combining Clinical Trial and Real-world Data Provide Further Insights into Which Patients May Benefit Most from Therapy: Demonstration for a New Oral Antiplatelet Therapy”. Pharmacoepidemiol Drug Saf. 2019;1–9.

    3. Tomas G Neilan, Mace L Rothenberg, Laleh Amiri-Kordestani, Ryan J Sullivan, Richard M Steingart, William Gregory, Subramanian Hariharan, Tarek Hammad, JoAnn Lindenfeld, Martin J Murphy, and Javid J Moslehi, on behalf of the Checkpoint Inhibitor Safety Working Group. Myocarditis Associated With Immune Checkpoint Inhibitors: an Expert Consensus on Data Gaps and a Path Forward. The Oncologist 2018;23:1–5 (

    4. R Williams, TP van Staa, AM Gallagher,TA Hammad, HGM Leufkens, F de Vries. “Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study”. BMJ Open. 2018 May 26;8(5).

    5. Tarek A. Hammad, Cathy Anne Pinto. "Key changes in benefit-risk assessment guidelines: methodological and analytical considerations for drug development". Statistics in Biopharmaceutical Research, Taylor & Francis Online (Dec 2016). Available at:

    6. Smith, MY; Hammad, Tarek A; Metcalf, M; et al. “Patient Engagement at a Tipping Point: The Need for Cultural Change across Patient, Sponsor, and Regulator Stakeholders: Insights from the Drug Information Association Conference, Patient Engagement in Benefit‐Risk Assessment throughout the Life Cycle of Medical Products”. Therapeutic Innovation & Regulatory Science, 50.5 (Sep 2016): 546-553.

    7. Elizabeth M. Kang, Simone P. Pinheiro, Tarek A. Hammad, Adel Abou-Ali. “Evaluating the validity of clinical codes to identify cataract and glaucoma in the UK Clinical Practice Research Datalink”. Pharmacoepidemiology and Drug Safety 2014. DOI: 10.1002/pds.3726

    8. Lyndsay A. Avalos, Hong Chen, Chunmei Yang, Susan E. Andrade, William O. Cooper, Craig T. Cheetham, Robert L. Davis, Sascha Dublin, Tarek A. Hammad, Sigal Kaplan, Pamala A. Pawloski, Marsha A. Raebel, Pamela E. Scott, David H. Smith, Sengwee Toh, De-Kun Li. The Prevalence and Trends of Antiviral Medication Use During Pregnancy in the US: A Population-Based Study of 664,297 Deliveries in 2001–2007. Maternal and Child Health Journal 2014, Volume 18, Issue 1, pp 64-72

    9. Tarek A. Hammad, George A. Neyarapally, Solomon Iyasu, Judy A. Staffa, Gerald Dal Pan. “The Future of Population-Based Postmarket Drug Risk Assessment: A Regulator’s Perspective”. Clinical Pharmacology & Therapeutics, advance online publication 10 July 2013. doi:10.1038/clpt.2013.118.

    10. Tarek A. Hammad, George A. Neyarapally, Simone P. Pinheiro, Solomon Iyasu, C. George Rochester, Gerald Dal Pan. "Reporting of Meta-Analyses of Randomized Controlled Trials with a Focus on Drug Safety: An Empirical Assessment". Clinical Trials, 2013, Volume 10 Issue 3 June 2013 pp. 385 – 393, DOI: 10.1177/1740774513479467

    11. Tarek A. Hammad, Andrea V. Margulis, Yulan Ding, Marian M. Strazzeri, Holly Epperly. "Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink". Pharmacoepidemiology and Drug Safety, 2013; 22: 1233–123822: 1233–1238.DOI: 10.1002/pds.3511.

    12. Andrea V Margulis, Elizabeth M Kang, Tarek A Hammad. "Patterns of use of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort". Maternal and Child Health Journal, 2013. DOI 10.1007/s10995-013-1419-2

    13. Esther H. Zhou, Sigal Kaplan, Andrew Mosholder, David Moeny, Yulan Ding, Solomon Iyasu, Tarek A. Hammad. “Antidepressant Medication Dispensing among Montelukast Initiators”. Journal of Asthma, DOI: 10.3109/02770903.2013.823445.

    14. Simone P. Pinheiro, Elizabeth M. Kang, Clara Y. Kim, Laura A. Governale, Esther H. Zhou, Tarek A. Hammad. "Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States". Pharmacoepidemiology and drug safety 2013; 22: 1251–1257. DOI: 10.1002/pds.3481.

    15. Andrea V. Margulis, Adel Abou-Ali, Marian M. Strazzeri, Yulan Ding, Fatmatta Kuyateh, Eric Y. Frimpong, Mark S. Levenson, Tarek A. Hammad. “Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD”. Pharmacoepidemiology and drug safety (2013). DOI: 10.1002/pds.3462.

    16. Qian Li, Susan E. Andrade, William O. Cooper, Robert L. Davis, Sascha Dublin, Tarek A. Hammad, Pamala A. Pawloski, Simone P. Pinheiro, Marsha A. Raebel, Pamela E. Scott, David H. Smith, Inna Dashevsky, Katherine Haffenreffer, Karin E. Johnson, Sengwee Toh. "Validation of an Algorithm to Estimate Gestational Age in Electronic Health Plan Databases". Published in Pharmacoepidemiology and Drug Safety, 2013, DOI: 10.1002/pds.3407.

    17. Johnson KE, Beaton SJ, Andrade SE, Cheetham TC, Scott PE, Hammad TA, Dashevsky I, Cooper WO, Davis RL, Pawloski PA, Raebel MA, Smith DH, Toh S, Li DK, Haffenreffer K, Dublin S. ”Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes.” Pharmacoepidemiol Drug Saf. 2013 Apr 18. doi: 10.1002/pds.3443.

    18. Sengwee Toh, Qian Li, T. Craig Cheetham, William O. Cooper, Robert L. Davis, Sascha Dublin, Simone P. Pinheiro, De-Kun Li, Pamala A. Pawloski, Tarek A. Hammad, Marsha A. Raebel, Pamela E. Scott, David H. Smith, William V. Bobo, Jean M. Lawrence, Inna Dashevsky, Katherine Haffenreffer, Lyndsay A. Avalos, Susan E. Andrade. "Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: A population-based study of 585,615 deliveries". Archives of Women's Mental Health, Archives of Women's Mental Health, 2013 Apr;16(2):149-57. doi: 10.1007/s00737-013-0330-6.

    19. Jean M. Lawrence, Susan E. Andrade, Lyndsay A. Avalos, Sarah J. Beaton, Vicki Y. Chiu, Robert L. Davis, Sascha Dublin, Pamala A. Pawloski, Marsha A. Raebel, David H. Smith, Sengwee Toh, Jean Q. Wang, Sigal Kaplan, Thushi Amini, Christian Hampp, Tarek A. Hammad, Pamela E. Scott, and T. Craig Cheetham."Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007". Obstet Gynecol 2013;121:106–14.

    20. Qian Li, Susan E. Andrade, William O. Cooper, Robert L. Davis, Sascha Dublin, Tarek A. Hammad, Pamala A. Pawloski, Simone P. Pinheiro, Marsha A. Raebel, Pamela E. Scott, David H. Smith, Inna Dashevsky, Katherine Haffenreffer, Karin E. Johnson, Sengwee Toh. "Validation of an Algorithm to Estimate Gestational Age in Electronic Health Plan Databases". Pharmacoepidemiology and Drug Safety, 2013, DOI: 10.1002/pds.3407.

    21. R Boggon, TP van Staa, M Chapman, AM Gallagher, TA Hammad, MA Richards "Cancer recording and mortality in the General Practice Research Database and linked cancer registries". Pharmacoepidemiology and Drug Safety, 2013 Feb;22(2):168-75. doi: 10.1002/pds.3374.

    22. Jarow Jonathan, Fang Xin, Tarek A Hammad. ”Variability of Semen Parameters Over Time in Placebo-Treated Men.” Journal of Urology, 2013 May;189(5):1825-9. doi: 10.1016/j.juro.2012.11.077.

    23. William V. Bobo, Robert L. Davis, Sengwee Toh, De-Kun Li, Susan E. Andrade, T. Craig Cheetham, Pamala Pawloski, Sascha Dublin, Simone Pinheiro, Tarek Hammad, Pamela E. Scott, Richard A. Epstein, Jr., Patrick G. Arbogast, James A. Morrow, Judith A. Dudley, Jean M. Lawrence, Lyndsay A. Avalos, William O. Cooperk. “Trends in the Use of Antiepileptic Drugs among Pregnant Women in the US, 2001–2007: A Medication Exposure in Pregnancy Risk Evaluation Program”. Paediatric and Perinatal Epidemiology, 2012, 26, 578–588.

    24. Du DT, Zhou EH, Goldsmith J, Nardinelli C, Hammad TA. “Atomoxetine use during a period of FDA actions”. Med Care. 2012 Nov;50(11):987-992.

    25. Craig Hansen, Peter Joski, Heather Freiman, Susan Andrade, Sengwee Toh, Sascha Dublin, Craig Cheetham, William Cooper, Pamala Pawloski, De-Kun Li, Sarah Beaton, Sigal Kaplan, Pamela Scott, Tarek Hammad, Robert Davis. "Medication Exposure in Pregnancy Risk Evaluation Program:The Prevalence of Asthma Medication Use During Pregnancy". Maternal and Child Health Journal, DOI 10.1007/s10995-012-1173-x

    26. George A Neyarapally, Tarek A Hammad, Simone P Pinheiro, Solomon Iyasu.”Review of quality assessment tools for the evaluation of pharmacoepidemiological safety studies”. BMJ Open 2012;2:e001362.doi:10.1136/bmjopen-2012-001362

    27. Susan E. Andrade, Pamela E. Scott, Robert L. Davis, De-Kun Li, Darios Getahun, T. Craig Cheetham, Marsha A. Raebel, Sengwee Toh, Sascha Dublin, Pamala A. Pawloski, Tarek A. Hammad, Sarah J. Beaton, David H. Smith, Inna Dashevsky, Katherine Haffenreffer, William O. Cooper. " Validity of health plan and birth certificate data for pregnancy research", Pharmacoepidemiology and Drug Safety. Article first published online: 3 JUL 2012. DOI: 10.1002/pds.3319

    28. Andrade SE, Davis RL, Cheetham TC, Cooper WO, Li DK, Amini T, Beaton SJ, Dublin S, Hammad TA, Pawloski PA, Raebel MA, Smith DH, Staffa JA, Toh S, Dashevsky I, Haffenreffer K, Lane K, Platt R, Scott PE. "Medication Exposure in Pregnancy Risk Evaluation Program". Matern Child Health J. 2011 Oct 15. [Epub ahead of print] PubMed PMID: 22002179.

    29. Tarek A. Hammad, Simone P. Pinheiro, George A. Neyarapally. “Secondary Use of Randomized Controlled Trials to Evaluate Drug Safety: a Review of Methodological Considerations”. Clinical Trials 2011; 8(5):559-570.

    30. Hany Aly, Tarek A. Hammad, Jonah Essers, Jen T. Wung. “Is mechanical ventilation associated with intraventricular hemorrhage in preterm infants?”. Brain and Development, 2012; 34(3): 201–205.

    31. Ann W. McMahon1, Robert G. Pratt, Tarek A. Hammad, Steven Kozlowski, Esther Zhou, Susan Lu, Corrinne G. Kulick, Tarun Mallick and Gerald Dal Pan. “Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008”. Pharmacoepidemiology and Drug Safety 2010; 19: 921–933.

    32. Aly H, Hammad TA, Ozen M, Sandhu I, Taylor C, Olaode A, Mohamed M, Keiser J. “Nasal Colonization among Premature Infants Treated with Nasal Continuous Positive Airway Pressure”. Am J Perinatol. 2010 Nov 29. PMID: 21117015

    33. Aly H, Bianco-Batlles D, Mohamed MA, Hammad TA. Mortality in infants with congenital diaphragmatic hernia: a study of the United States National Database. J Perinatol. 2010 Aug;30(8):553-7. Epub 2010 Feb 11.PMID: 20147959.

    34. Pamer C, Hammad TA, Yu Te, Kaplan S, , Rochester G., Laura Governale, Mosholder AD. “Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiology and Drug Safety 2010; 19: 158–174.

    35. Scott Devine, Suzanne West, Elizabeth Andrews, Pat Tennis, Tarek A. Hammad, Susan Eaton, John Thorp, Andrew Olshan. "The Identification of Pregnancies Within The General Practice Research Database". Pharmacoepidemiology and Drug Safety, 2010; 19: 45–50.

    36. Hany Aly, Tarek A Hammad, Ayman Nada, Mohamed Mohamed, Susanne Bathgate, Ayman El-Mohandes. “Maternal Obesity, Associated Complications, and Risk of Prematurity”. J Perinatol. (2010) 30, 447–451.

    37. Ceyda Acuna, Asra Tanveer, Elsie Lee, Mohamed Mohamed, An Massaro, Tarek A. Hammad, Hany Aly. “ABO phenotype and sepsis in very low birth weight infants”. Journal of Pediatric Infectious Diseases, 2009; 4:1–3.

    38. Andrew D. Mosholder, Kate Gelperin, Tarek A. Hammad, Kathleen Phelan, Rosemary Johann-Liang. “Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children”. Pediatrics, 2009, 123 (2).

    39. Mohamed R. Bassiouny, Hala Almarsafawy, Hesham Abdel-Hady, Nehad Nasef, Tarek A. Hammad, Hany Aly. "A Randomized Controlled Trial on Parenteral Nutrition, Oxidative Stress and Chronic Lung Diseases in Preterm Infants". Journal of Pediatric Gastroenterology and Nutrition, 2009 Mar;48(3):363-9.

    40. An N. Massaro, Tarek A. Hammad, Barbara Jazzo, and Hany Aly. "Massage With Kinesthetic Stimulation Improves Weight Gain In Preterm Infants ". Journal of Perinatology, 2009 May;29(5):352-7.

    41. Aly, Hany; Massaro, An; Hammad, Tarek A; Narang, Sherry; Essers, Jonah. “Early Nasal Continuous Positive Airway Pressure and Necrotizing Enterolocolitis in Very Low Birth Weight Preterm Infants”. Pediatrics, 2009; 124(1):205-10.

    42. Hammad TA, McAdams MA, Feight A, Iyasu S, Dal Pan GJ. “Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database”. Pharmacoepidemiology and Drug Safety, 2008; 17: 1197–1201.

    43. Marc Stone, Thomas Laughren, Lisa Jones, Mark Levenson, Chris Holland, Alice Hughes, Tarek A Hammad, Robert Temple, George Rochester. “Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration”. BMJ 2009;339:b2880.

    44. Mara A. McAdams, Kate Gelperin, Laura A. Governale, Lynette Swartz, Tarek A. Hammad, Gerald J. Dal Pan. “Identifying Patterns of Adverse Event Reporting for Four Members of the Angiotensin II Receptor Blockers Class of Drugs: Revisiting the Weber Effect”. Pharmacoepidemiology and Drug Safety, 2008; 17: 882–889.

    45. Aly H, Alhabashi G, Hammad TA, Owusu-Ansah S, Bathgate S, Mohamed M. ABO Phenotype and other risk factors associated with chorioamnionitis. J Pediatr 2008; 153: 16-18.

    46. Tetyana H. Nesterenko, Brian Nolan, Tarek A. Hammad, Hany Aly. "Exposure to Oxygen and head growth in Infants with bronchopulmonary dysplasia". American Journal of Perinatology, 2008;25:251–254.

    47. Tarek A Hammad, Graham DJ, Staffa JA, Kornegay CJ, Dal Pan G. “Onset of Acute Myocardial Infarction After Use of Non-steroidal Anti-inflammatory Drugs”. Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):315-21. The paper won an award as "one of the best papers published in Pharmacoepidemiology and Drug Safety (PDS) in the year 2008".

    48. Mohamed MA, Cunningham-Rundles S, Dean CR, Hammad TA, Nesin M. “Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls.” Cytokine. 2007 Sep;39(3):171-7.

    49. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Tarek A. Hammad. Oral Ibuprofen and Ductus Arteriosus in Premature Infants: A Randomized Pilot Study. Am J Perinatol. 2007, 24(5):267-270.

    50. Tarek A. Hammad, T. Laughren, J. Racoosin. “Suicide Rates in Short-Term Randomized Controlled Trials of Newer Antidepressants”. Journal of Clinical Psychopharmacology, 2006, 26(2):203–207.

    51. Tarek A. Hammad, T. Laughren, J. Racoosin. “Suicidality in Pediatric Patients Treated with Antidepressants”. JAMA Psychiatry ( formerly, Archives of General Psychiatry),2006, 63:332-339.

    52. M.M. El-Masri, Tarek A. Hammad, S. Fox-Wasylyshyn. “Using Surrogate Markers of Injury Severity in Predicting Nosocomial Bloodstream Infections: A Methodological Perspective”. Nursing Research, 2005, 54(4):273-279.

    53. M.M. El-Masri, Tarek A. Hammad, S. W. McLeskey, M Joshi, D. M. Korniewicz. “Predictors of Nosocomial Bloodstream Infections among the Critically Ill Adult Trauma Population”. Infection Control and Hospital Epidemiology, 2004, 25 (8):656-663.

    54. Tarek A. Hammad. “Structure Modification in Knee Osteoarthritis: Methodology and Outcome Parameters”. Osteoarthritis and Cartilage, 2001, 9(5):488-498.

    55. R. Hanson, Brawner W.R., Blaik M.A., Tarek A. Hammad, Kincaid S.A., Pugh D.G. “Oral Treatment with a Nutraceutical for Ameliorating Signs of Navicular Syndrome in Horses”. Veterinary Therapeutics, 2001, 2(2):148-159.

    56. W. AbdelFattah, Tarek A. Hammad. “Chondroitin Sulfate and Glucosamine: A Review of their Safety Profile”. Journal of the American Nutraceutical Association, 2001, 3(2):16-23.

    57. N. S. Gabr, Tarek A. Hammad, A. Orieby, E. Shawky, M. A. Khattab, G. T. Strickland. “The Epidemiology of Schistosomiasis in Egypt: Minya Governorate”. American Journal of Tropical Medicine and Hygiene, 2000, 62(2 Suppl):65-72.

    58. D. Hungerford, R. Navarro, Tarek A. Hammad. “Use of Nutraceuticals in the Management of Osteoarthritis”. A “Continuing Education” approved review article. Journal of the American Nutraceutical Association, 2000, 3(1):23-27.

    59. L. Lippiello, J. Woodward, R. Karpman, Tarek A. Hammad. “In-vivo Chondroprotection and Metabolic Synergy of Glucosamine and Chondroitin Sulfate”. Journal of Clinical Orthopedic Related Research, 2000, 381:229-240.

    60. A. Das, Tarek A. Hammad. “Efficacy of a Combination of FCHG49™ Glucosamine Hydrochloride, TRH122™ Low Molecular Weight Sodium Chondroitin Sulfate And Manganese Ascorbate in the Management of Knee Osteoarthritis”. Osteoarthritis and Cartilage, 2000, 8(5):343-350.

    61. M. Anderson, M. Slater, Tarek A. Hammad. “Results of a Survey of Small-Animals Practitioners on the Perceived Clinical Efficacy and Safety of an Oral Nutraceutical”. Preventive Veterinary Medicine, 1999, 38:65-73.

    62. R. R. Hanson, L. R. Smalley, G. K. Huff, S. White, Tarek A. Hammad: “Treatment with an oral glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases”. Equine Practice, 1997, 19(9):16-20.

    63. Tarek A. Hammad, N. S. Gabr, M. H. Hussein, A. Orieby, E. Shawky, P. Langenberg, J. Scott and G. T. Strickland. "Determinants of Infection with Schistosomiasis Haematobia Using Logistic Regression". American Journal of Tropical Medicine and Hygiene, 1997, 57(4):464-468.

    64. Tarek A. Hammad, N. S. Gabr, M. H. Hussein, A. Orieby, E. Shawky and G. T. Strickland. "Hematuria and Proteinuria as Predictors of S.haematobium Infection". American Journal of Tropical Medicine and Hygiene, 1997, 57(3):363-367.

    65. Tarek A. Hammad, S. Havas, D. Damron, P. Langenberg. "Withdrawal Rates of Infants and Children Participating in the WIC Program in Maryland". Journal of American Dietetic Association, 1997, 97 (8):893-895.

    66. S. Havas, D. Damron, K. Treiman, J. Anliker, P. Langenberg, Tarek A. Hammad, V. Freimuth and R. Feldman. "The Maryland WIC 5 A Day Promotion Program Pilot Study: Rationale, Results and Lessons Learned". Journal of Nutrition Education, 1997, 29:343-350.

    67. Tarek A. Hammad, M. F. Abdel-Wahab, N. DeClaris, A. El-Sahly, N. El-Kady and G. T. Strickland. "Comparative Evaluation of Artificial Neural Networks Modeling of the Epidemiology of Schistosomiasis Mansoni". Transaction of the Royal Society of Tropical Medicine and Hygiene, 1996, 90: 372-376.

    68. Tarek A. Hammad, M. Sexton and P. Langenberg. "Relationship between Blood Lead and Dietary Iron Intake in Preschool Children: a Cross-sectional Study". Annals of Epidemiology, 1996, 6(1):30-33.

    69. M. Afifi, Tarek A. Hammad, N. Gabr, S. El-Shinawi, R. Khalifa and M. Azab. "Application of Neural Networks as a Novel Approach for Real-time Diagnosis of Acute Toxoplasma Infection in Immunocompetent Patients". Clinical Infectious Diseases, 1995, 21:1411-1416.

Book Chapters/Books

    1. CIOMS Working Group X. Evidence Synthesis and Meta-Analysis for Drug Safety: Report of CIOMS Working Group X. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS). ISBN : 978-92-9036-085-8. 2016

    2. Hammad TA, Neyarapally GA. (2016). Regulatory and Legislative Policy and Science Considerations in the Era of Patient-Centeredness, Big Data, and Value. In: Jiang Q, He W (eds.) “Benefit-Risk Assessment Methods in Medicinal Product Development: Bridging Qualitative and Quantitative Assessments”. CRC Press Taylor and Francis Group, Boca Raton FL.

    3. Computational Intelligence: Neural Networks methodology (Chapter 9, p 199-217). In: Health Decision Support Systems. Drs Joseph Tan and Samuel Sheps (Eds), Aspen Publishers, Inc., Gaithersburg, MD (ISBN: 0-8342-1065-7), 1998.